Business Context and Reporting Period
This Form 8-K filing by Ellington Financial LLC (the "Company") reports a material definitive agreement entered into on May 8, 2013. The report was filed on May 13, 2013. The Company is a Delaware limited liability company focused on financial investments.
Key Financial Metrics
The filing details a public offering of common shares representing limited liability company interests. Key financial terms include:
- Shares Offered: 5,000,000 Common Shares.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 750,000 additional shares.
- Expected Net Proceeds: Approximately $125.4 million after underwriting discounts, commissions, and estimated offering expenses.
- Expected Closing Date: May 14, 2013.
The filing does not provide specific data on revenue, profit, cash flow, margins, or existing debt levels for the reporting period.
Material Changes
The primary material change is the execution of an underwriting agreement for the sale of equity. This transaction is expected to significantly increase the Company's liquidity upon closing. The offering is being made pursuant to a shelf registration statement on Form S-3 (File No. 333-177754) declared effective on May 3, 2013.
Guidance, Outlook, and Risks
Management Commentary: The Company has engaged Merrill Lynch, Pierce, Fenner & Smith Incorporated, Deutsche Bank Securities, Credit Suisse Securities (USA) LLC, and UBS Securities LLC as representatives of the underwriters. The agreement includes customary representations, warranties, indemnification rights, and termination provisions.
Risks and Contingencies: The closing of the offering is subject to customary closing conditions. The Company has agreed to indemnify the underwriters against certain liabilities under the Securities Act of 1933 and to reimburse them for certain expenses. Future business relationships with the underwriters may involve customary fees for financing and advisory services.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received, as the $125.4 million figure is an estimate.
- Confirm whether the underwriters exercised the 30-day option to purchase the additional 750,000 shares.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific covenants and termination rights.
- Check subsequent filings for the impact of this capital raise on the Company's balance sheet and leverage ratios.